SCHEMBL13745247

SCHEMBL13745247

CCC(C)[C@H]1C(=O)N(CC2CCCCC2)C[C@H]2N1C(=O)N(C)N2C(=O)NCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CLPP Q16740 18/20 0.49
▸ KMT2A Q03164 1/20 0.40
▸ CNR1 P21554 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10224742 0.89 CLPP (0.51) CLPP
SCHEMBL13744999 0.87 CLPP (0.51) CLPP
SCHEMBL748404 0.83 CLPP (0.48) CLPP
SCHEMBL13745014 0.82 CLPP (0.53) CLPP
SCHEMBL750149 0.81 CLPP (0.45) CLPP
SCHEMBL10224738 0.81 CLPP (0.42) CLPPKMT2ACNR1
SCHEMBL749825 0.80 CLPP (0.52) CLPP
SCHEMBL745933 0.76 CLPP (0.49) CLPP
SCHEMBL762015 0.76 CLPP (0.51) CLPPKMT2A
SCHEMBL745480 0.76 CLPP (0.59) CLPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2009-08-27 — — US disclosed
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2009-08-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION MYLK2, TNNC1, MYH2 CLPP 3986/4885KMT2A 3153/4885CNR1 4284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback